By Professor Jerry Richard Greenfield

Journal articles

Patel SK; Fourlanos S; Greenfield JR, 2021, 'Comment on ‘impact of routine Clinic Measurement of random Serum c-peptide in people with a Clinician Diagnosis of type 1 diabetes’', Diabetic Medicine, 38, http://dx.doi.org/10.1111/dme.14513

Bishay RH; Tonks KT; George J; Samocha-Bonet D; Meyerowitz-Katz G; Chisholm DJ; James DE; Greenfield JR, 2021, 'Plasma Bile Acids More Closely Align with Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity', Journal of Clinical Endocrinology and Metabolism, 106, pp. E1131 - E1139, http://dx.doi.org/10.1210/clinem/dgaa940

Milder TY; Stocker SL; Day RO; Greenfield JR, 2020, 'Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease', Drug Safety, 43, pp. 1211 - 1221, http://dx.doi.org/10.1007/s40264-020-01010-6

Lasschuit JWJ; Center JR; Greenfield JR; Tonks KTT, 2020, 'Comparison of calcaneal quantitative ultrasound and bone densitometry parameters as fracture risk predictors in type 2 diabetes mellitus', Diabetic Medicine, 37, pp. 1902 - 1909, http://dx.doi.org/10.1111/dme.14183

Htet TD; Godneva A; Liu Z; Chalmers E; Kolobkov D; Snaith JR; Richens R; Toth K; Danta M; Hng TM; Elinav E; Segal E; Greenfield JR; Samocha-Bonet D, 2020, 'Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin', BMJ Open, 10, pp. e037859, http://dx.doi.org/10.1136/bmjopen-2020-037859

Snaith JR; Holmes-Walker DJ; Greenfield JR, 2020, 'Letter to the editor: ⇜risk factors for cardiovascular disease (CVD) in adults with type 1 diabetes: findings from prospective real-life T1D exchange registry”', Journal of Clinical Endocrinology and Metabolism, 105, pp. 1 - 2, http://dx.doi.org/10.1210/clinem/dgaa383

Hussain I; Jin RR; Baum HBA; Greenfield JR; Devery S; Xing C; Hegele RA; Carranza-Leon BG; Linton MF; Vuitch F; Wu KHC; Precioso DR; Oshima J; Agarwal AK; Garg A, 2020, 'Multisystem progeroid syndrome with lipodystrophy, cardiomyopathy, and nephropathy due to an LMNA p.R349W variant', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa104

Martin C; Ait Boudaoud A; Poghosyan T; Zhu J; Larger E; Greenfield JR; Czernichow S; Rives-Lange C; Carette C, 2020, 'Prevalence of anti-GAD and IA2 autoantibodies in a French cohort of patients with diabetes eligible for bariatric surgery', Diabetes and Metabolism, 46, pp. 407 - 409, http://dx.doi.org/10.1016/j.diabet.2019.12.004

Snaith JR; Greenfield JR, 2020, 'COVID-19: it's changed us', Internal Medicine Journal, 50, pp. 1162 - 1163, http://dx.doi.org/10.1111/imj.14968

Muir CA; Jones GRD; Greenfield JR; Weissberger A; Samaras K, 2020, 'THYROID PEROXIDASE ANTIBODY POSITIVITY IS ASSOCIATED with RELAPSE-FREE SURVIVAL following ANTITHYROID DRUG TREATMENT for GRAVES DISEASE', Endocrine Practice, 26, pp. 1026 - 1030, http://dx.doi.org/10.4158/EP-2020-0035

Mortimer B; Naganur VD; Satouris P; Greenfield JR; Torpy DJ; Rushworth RL, 2020, 'Acute illness in patients with concomitant Addison's disease and type 1 diabetes mellitus: Increased incidence of hypoglycaemia and adrenal crises', Clinical Endocrinology, 93, pp. 104 - 110, http://dx.doi.org/10.1111/cen.14219

Lasschuit JWJ; Greenfield JR; Tonks KT, 2020, 'High Risk Foot Service reduces number of Emergency Department presentations and length of stay', Diabetes and Metabolism, 46, pp. 252 - 255, http://dx.doi.org/10.1016/j.diabet.2018.07.002

Snaith JR; Samocha-Bonet D; Holmes-Walker DJ; Greenfield JR, 2020, 'MON-LB113 Insulin Resistance in Type 1 Diabetes Managed With Metformin (INTIMET): Rationale and Study Design of a Randomised Placebo-Controlled Trial', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa046.2038

Muir CA; Greenfield JR; Weissberger A; Jones GRD; Samaras K, 2020, 'SAT-LB75 Thyroid Peroxidase Antibody Positivity Predicts Relapse Free Survival Following Anti-Thyroid Drug Treatment for Graves Disease', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa046.2016

Milder TY; Day RO; Stocker SL; Greenfield JR, 2020, 'Should the cardio-protective properties of sodium-glucose cotransporter 2 inhibitors dictate therapeutic decision-making in patients with type 2 diabetes', Internal Medicine Journal, 50, pp. 645 - 646, http://dx.doi.org/10.1111/imj.14819

Smith FC; Stocker SL; Danta M; Carland JE; Kumar SS; Liu Z; Greenfield JR; Braithwaite HE; Cheng TS; Graham GG; Williams KM; Day RO, 2020, 'The safety and pharmacokinetics of metformin in patients with chronic liver disease', Alimentary Pharmacology and Therapeutics, 51, pp. 565 - 575, http://dx.doi.org/10.1111/apt.15635

Snaith JR; Holmes-Walker DJ; Greenfield JR, 2020, 'Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?', Trends in Endocrinology and Metabolism, 31, pp. 150 - 164, http://dx.doi.org/10.1016/j.tem.2019.11.007

Harari A; Coster ACF; Jenkins A; Xu A; Greenfield JR; Harats D; Shaish A; Samocha-Bonet D, 2020, 'Obesity and Insulin Resistance Are Inversely Associated with Serum and Adipose Tissue Carotenoid Concentrations in Adults', Journal of Nutrition, 150, pp. 38 - 46, http://dx.doi.org/10.1093/jn/nxz184

Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte MV, 2020, '1133 PANCREATIC STELLATE CELL AND CANCER CELL DERIVED EXOSOMES IMPAIR BETA CELL FUNCTION: IMPLICATIONS FOR PANCREATIC CANCER RELATED DIABETES.', Gastroenterology, 158, pp. S - 221, http://dx.doi.org/10.1016/s0016-5085(20)31245-2

Abdel Shaheed C; Carland JE; Graham GG; Stocker SL; Smith G; Hicks M; Williams KM; Furlong T; Macdonald P; Greenfield JR; Smith FC; Chowdhury G; Day RO, 2019, 'Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis', British Journal of Clinical Pharmacology, 85, pp. 2772 - 2783, http://dx.doi.org/10.1111/bcp.14107

Milder TY; Stocker SL; Samocha-Bonet D; Day RO; Greenfield JR, 2019, 'Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes—cardiovascular and renal benefits in patients with chronic kidney disease', European Journal of Clinical Pharmacology, 75, pp. 1481 - 1490, http://dx.doi.org/10.1007/s00228-019-02732-y

Greenfield JR; Carette C; Czernichow S, 2019, 'Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults', The New England journal of medicine, 381, pp. e17, http://dx.doi.org/10.1056/NEJMc1908751

Snaith JR; Holmes-Walker DJ; Greenfield JR, 2019, 'Association of insulin dose, cardiometabolic risk factors, and cardiovascular disease in type 1 diabetes during 30 years of follow-up in the DCCT/EDIC study. Diabetes care 2019;42:657-664', Diabetes Care, 42, pp. E135 - E136, http://dx.doi.org/10.2337/dc19-0730

Cehic MG; Muir CA; Greenfield JR; Hayward C; Jabbour A; Keogh A; Kotlyar E; Muthiah K; Macdonald PS, 2019, 'Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients', Transplantation Direct, 5, pp. e450, http://dx.doi.org/10.1097/TXD.0000000000000885

Tang A; Coster ACF; Tonks KT; Heilbronn LK; Pocock N; Purtell L; Govendir M; Blythe J; Zhang J; Xu A; Chisholm DJ; Johnson NA; Greenfield JR; Samocha-Bonet D, 2019, 'Longitudinal changes in insulin resistance in normal weight, overweight and obese individuals', Journal of Clinical Medicine, 8, pp. 623, http://dx.doi.org/10.3390/jcm8050623

Muir C; Dwight T; Center J; Greenfield J; Clifton-Bligh R; Lee P, 2019, 'MON-378 Somatic HIF2α Mutation and Pheochromocytoma in a Patient with Cyanotic Congenital Heart Disease', Journal of the Endocrine Society, 3, http://dx.doi.org/10.1210/js.2019-mon-378

Taylor JE; Campbell LV; Greenfield JR, 2019, 'Author reply', Internal Medicine Journal, 49, pp. 552, http://dx.doi.org/10.1111/imj.14255

Snaith JR; Holmes-Walker DJ; Girgis CM; Greenfield JR, 2019, 'Excess mortality and cardiovascular disease risk in type 1 diabetes', The Lancet, 393, pp. 984 - 985, http://dx.doi.org/10.1016/S0140-6736(18)33050-2

Milder TY; Stocker SL; Shaheed CA; McGrath-Cadell L; Samocha-Bonet D; Greenfield JR; Day RO, 2019, 'Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis', JOURNAL OF CLINICAL MEDICINE, 8, http://dx.doi.org/10.3390/jcm8010045

Patel S; Chin V; Greenfield JR, 2019, 'Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism', Endocrinology, Diabetes and Metabolism Case Reports, 2019, http://dx.doi.org/10.1530/EDM-19-0098

Lenders NF; Greenfield JR, 2019, 'Urinary steroid profiling in diagnostic evaluation of an unusual adrenal mass', Endocrinology, Diabetes and Metabolism Case Reports, 2019, http://dx.doi.org/10.1530/EDM-19-0090

Greenfield J, 2019, 'Challenges to obesity research in humans: the power of human phenomic studies', Obesity Research & Clinical Practice, 13, pp. 272 - 272, http://dx.doi.org/10.1016/j.orcp.2018.11.106

Bishay RH; Tonks KT; George J; Samocha-Bonet D; Chisholm DJ; James DE; Greenfield JR, 2019, 'Circulating bile acids are associated with insulin resistance and visceral and liver fat in human subjects', Obesity Research & Clinical Practice, 13, pp. 28 - 29, http://dx.doi.org/10.1016/j.orcp.2016.10.030

Tang A; Tonks KT; Heilbronn LK; Pocock NA; Campbell LV; James DE; Chisholm DJ; Greenfield JR; Samocha-Bonet D, 2019, 'Insulin-sensitive overweight/obese individuals remain as insulin sensitive and normotensive as lean subjects over 6 years', Obesity Research & Clinical Practice, 13, pp. 35 - 35, http://dx.doi.org/10.1016/j.orcp.2016.10.042

Koay YC; Yang P; Chen D; Jenkins AB; Greenfield J; O'Sullvan JF; Samocha-Bonet D, 2019, 'Novel circulating biomarkers identify insulin resistance phenotypes in obesity', Obesity Research & Clinical Practice, 13, pp. 267 - 268, http://dx.doi.org/10.1016/j.orcp.2018.11.092

Taylor JE; Campbell LV; Zhang L; Greenfield JR, 2018, 'High diabetes prevalence and insulin medication errors in hospital patients', Internal Medicine Journal, 48, pp. 1529 - 1532, http://dx.doi.org/10.1111/imj.14124

Lasschuit J; Greenfield J, 2018, 'Managing complex cases of diabetes', Endocrinology Today, 7, pp. 20 - 24

Kumar SS; McManus H; Radovich T; Greenfield JR; Viardot A; Williams KM; Cronin P; Day RO, 2018, 'Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM)', European Journal of Clinical Pharmacology, 74, pp. 1327 - 1332, http://dx.doi.org/10.1007/s00228-018-2506-5

Isaacs M; Costin M; Bova R; Barrett HL; Heffernan D; Samaras K; Greenfield JR, 2018, 'Management of amiodarone-induced thyrotoxicosis at a cardiac transplantation centre', Frontiers in Endocrinology, 9, http://dx.doi.org/10.3389/fendo.2018.00482

Fazekas-Lavu M; Reyes M; Malouf M; Plit M; Havryk A; Campbell LV; Center JR; Glanville AR; Greenfield JR, 2018, 'High prevalence of diabetes before and after lung transplantation: target for improving outcome?', Internal Medicine Journal, 48, pp. 916 - 924, http://dx.doi.org/10.1111/imj.13963

Du YT; Piscitelli D; Ahmad S; Trahair LG; Greenfield JR; Samocha-Bonet D; Rayner CK; Horowitz M; Jones KL, 2018, 'Effects of glutamine on gastric emptying of lowand high-nutrient drinks in healthy young subjects—impact on glycaemia', Nutrients, 10, http://dx.doi.org/10.3390/nu10060739

Samocha-Bonet D; Debs S; Greenfield JR, 2018, 'Prevention and Treatment of Type 2 Diabetes: A Pathophysiological-Based Approach', Trends in Endocrinology and Metabolism, 29, pp. 370 - 379, http://dx.doi.org/10.1016/j.tem.2018.03.014

Htet TD; Campbell L; Greenfield J, 2018, 'Burden of obesity and focus on use of Liraglutide (Saxenda) 3.0mg for weight loss in adults', The Medical Republic

Ma C; Tonks KT; Center JR; Samocha-Bonet D; Greenfield JR, 2018, 'Complex interplay among adiposity, insulin resistance and bone health', Clinical Obesity, 8, pp. 131 - 139, http://dx.doi.org/10.1111/cob.12240

Greenfield JR; Ho K, 2018, 'Paul Lee, 1977-2017', Internal medicine journal, 48, pp. 381 - 382, http://dx.doi.org/10.1111/imj.13760

Fazakerley DJ; Chaudhuri R; Yang P; Maghzal GJ; Thomas KC; Krycer JR; Humphrey SJ; Parker BL; Fisher-Wellman KH; Meoli CC; Hoffman NJ; Diskin C; Burchfield JG; Cowley MJ; Kaplan W; Modrusan Z; Kolumam G; Yang JYH; Chen DL; Samocha-Bonet D; Greenfield JR; Hoehn KL; Stocker R; James DE; Chen D; Southwell Keely P, 2018, 'Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance', eLife, 7, pp. e32111, http://dx.doi.org/10.7554/eLife.32111

Cehic MG; Nundall N; Greenfield JR; Macdonald PS, 2018, 'Management Strategies for Posttransplant Diabetes Mellitus after Heart Transplantation: A Review', Journal of Transplantation, 2018, pp. 1025893, http://dx.doi.org/10.1155/2018/1025893

Chemmanam J; Isaacs M; Jones GR; Greenfield JR; Burt MG, 2017, 'Interpreting insulin immunoassays during investigation of apparent spontaneous hypoglycaemia and insulin overdose', Internal Medicine Journal, 47, pp. 1448 - 1451, http://dx.doi.org/10.1111/imj.13644

Bishay RH; Greenfield JR, 2017, 'A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY', Medical Journal of Australia, 207, pp. 223 - 223.e1, http://dx.doi.org/10.5694/mja16.01467

Kozan P; Blythe JC; Greenfield JR; Samocha-Bonet D, 2017, 'The effect of buffering high acid load meal with sodium bicarbonate on postprandial glucose metabolism in humans—A randomized placebo-controlled study', Nutrients, 9, pp. 861, http://dx.doi.org/10.3390/nu9080861

Back to profile page